Why do the same medicines cost more in Armenia than in neighboring Georgia, and what is preventing everyone from having access to affordable medication? One of the reasons is the structure of the market, where three major companies control a significant share of medicine distribution, affecting competition.
Limited competition is not the only problem. Medicine shortages have also become a persistent issue in Armenia, making access to medication even more difficult.
Georgia has a reference pricing system, and medicines are exempt from value-added tax. These two factors significantly reduce drug prices, creating different pricing conditions in the neighboring country.
A comparison between Armenia and Georgia shows that the price gap cannot be explained solely by the pricing policies of individual pharmacies. The problem is also linked to market structure and government pricing mechanisms.
Access to medicines is not just a healthcare system issue; it also directly affects families' everyday expenses. When the same medicine is more affordable in a neighboring country, it naturally raises the question of why such different conditions have emerged in the two markets.
In Armenia, the focus should be on the competitive environment and pricing rules. If the influence of three major companies restricts competition, controlling pharmacy prices alone cannot fully resolve the problem. Georgia's example shows that government regulations can also have a direct impact on the final price of medicines.
However, the most important question remains unanswered: what changes are needed to make medicines more affordable in Armenia and put an end to persistent shortages? Without addressing both issues, the price gap will continue to concern consumers.

